SEC Form 4 · accession 0001225208-18-004489
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Young
Officer — Group President
Period of report
Feb 24, 2018
Accepted (ET)
Feb 27, 2018 · 8:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2018 | M | 43,520 | $18.90 | A | 223,733 | D | |
| Common StockF2,F3 | Feb 24, 2018 | F | 12,214 | $36.26 | D | 211,519 | D | |
| Common StockF4,F5 | Feb 24, 2018 | F | 13,886 | $35.98 | D | 197,633 | D | |
| Common Stock | holding | — | — | — | 1,703 | I | By Rule 16b-3 Plan | |
| Common Stock | holding | — | — | — | 1,423 | I | By Trustee under the Pfizer Share Ownership Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF6 | $18.90 | Feb 24, 2018 | M | 43,520 | D | Feb 24, 2018 | Feb 24, 2018 | Common Stock | 43,520 | 0 | D |
Explanation of responses
- F1The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- F2The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- F3Price is the closing price of Pfizer common stock on February 23, 2018
- F4The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- F5Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- F6The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.